Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP813651.RA_MvbraQgn3nDefB-2t_48tRM4r7j09IvfAw2vGe6s2g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP813651.RA_MvbraQgn3nDefB-2t_48tRM4r7j09IvfAw2vGe6s2g130_assertion type Assertion NP813651.RA_MvbraQgn3nDefB-2t_48tRM4r7j09IvfAw2vGe6s2g130_head.
- NP813651.RA_MvbraQgn3nDefB-2t_48tRM4r7j09IvfAw2vGe6s2g130_assertion description "[MiR-21 antagonism therefore emerges as an interesting strategy to improve dysfunctional APCs in patients with coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP813651.RA_MvbraQgn3nDefB-2t_48tRM4r7j09IvfAw2vGe6s2g130_provenance.
- NP813651.RA_MvbraQgn3nDefB-2t_48tRM4r7j09IvfAw2vGe6s2g130_assertion evidence source_evidence_literature NP813651.RA_MvbraQgn3nDefB-2t_48tRM4r7j09IvfAw2vGe6s2g130_provenance.
- NP813651.RA_MvbraQgn3nDefB-2t_48tRM4r7j09IvfAw2vGe6s2g130_assertion SIO_000772 20489163 NP813651.RA_MvbraQgn3nDefB-2t_48tRM4r7j09IvfAw2vGe6s2g130_provenance.
- NP813651.RA_MvbraQgn3nDefB-2t_48tRM4r7j09IvfAw2vGe6s2g130_assertion wasDerivedFrom befree-2016 NP813651.RA_MvbraQgn3nDefB-2t_48tRM4r7j09IvfAw2vGe6s2g130_provenance.
- NP813651.RA_MvbraQgn3nDefB-2t_48tRM4r7j09IvfAw2vGe6s2g130_assertion wasGeneratedBy ECO_0000203 NP813651.RA_MvbraQgn3nDefB-2t_48tRM4r7j09IvfAw2vGe6s2g130_provenance.